申请人:Cid-Nunez Jose Maria
公开号:US20080262076A1
公开(公告)日:2008-10-23
This invention concerns novel substituted tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain with binding affinities towards dopamine receptors, in particular dopamine D
2
receptors, towards serotonin receptors, in particular 5-HT
2A
and 5-HT
2C
receptors, and pharmaceutical compositions comprising the compounds according to the invention, the use thereof as a medicine, in particular for the prevention and/or treatment of a range of psychiatric and neurological disorders, in particular certain psychotic, cardiovascular and gastrokinetic disorders and processes for their production.
The compounds according to the invention can be represented by general Formula (I)
and comprises also a pharmaceutically acceptable acid or base addition salt thereof, an N-oxide form thereof or a quaternary ammonium salt thereof, wherein all substituents are defined as in Claim 1.
本发明涉及一种新型取代四环四氢呋喃衍生物,其含有一个环状胺侧链,具有结合多巴胺受体的亲和力,特别是多巴胺D2受体,对5-HT2A和5-HT2C受体的亲和力,以及包含根据本发明的化合物的制药组合物,其用作药物,特别是用于预防和/或治疗一系列精神和神经疾病,特别是某些精神病、心血管和胃动力紊乱,并提供其生产过程。根据本发明的化合物可以用一般式(I)表示,并包括其药学上可接受的酸或碱盐、N-氧化物形式或季铵盐,其中所有取代基在权利要求书1中定义。